<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cardiogenic factors which may contribute to the <z:hpo ids='HP_0001297'>stroke</z:hpo> syndrome have been discussed (Table 14.7) </plain></SENT>
<SENT sid="1" pm="."><plain>Pathophysiological mechanisms include emboli from rheumatic coronary and <z:hpo ids='HP_0002564'>congenital heart diseases</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Atherosclerotic disease and <z:hpo ids='HP_0000822'>hypertension</z:hpo> can involve both intracranial and extracranial arteries </plain></SENT>
<SENT sid="3" pm="."><plain>Disturbances in cardiac rhythm can significantly reduce cerebral blood flow </plain></SENT>
<SENT sid="4" pm="."><plain>The development of cerebral <z:mp ids='MP_0005039'>hypoxia</z:mp> with resuscitation is described </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment of these disorders is reviewed, and the potential role of metabolic support of the ischemic tissue both with cerebral and myocardial damage has been presented </plain></SENT>
</text></document>